Hyperthermic Intrathoracic Chemotherapy (HITHOC) is a specialised intraoperative procedure used in the management of advanced thymomas, particularly those with pleural dissemination - a pattern of disease spread where tumour deposits seed the pleural surfaces and cannot be fully resected by conventional surgery alone. The technique involves surgically removing all visible tumour from the pleural cavity (cytoreductive surgery), then circulating a heated chemotherapy solution directly through the chest cavity for 60 to 90 minutes before closure. Heat potentiates the cytotoxic effect of cisplatin against residual microscopic disease, while the direct intracavitary delivery achieves drug concentrations far higher than intravenous administration could safely sustain. Medanta is one of a very small number of centres in India to offer HITHOC as a standard surgical option, and it is integrated into a comprehensive thymoma treatment pathway that includes preoperative staging, multidisciplinary tumour board review, and long-term oncological follow-up.

The da Vinci Surgical System is considered superior to other robotic platforms because it provides high-definition 3D magnified vision, allowing surgeons to see fine anatomical details with exceptional clarity. Its advanced EndoWrist instruments offer greater dexterity and precision, closely mimicking the natural movements of the human hand while filtering tremors. Importantly, the da Vinci system is widely used worldwide and is regarded as an international gold-standard platform for robotic surgery. These advantages make it one of the most advanced, trusted, and globally accepted robotic technologies in modern surgery, enabling safer procedures and faster patient recovery.

Tissue sampling for precise diagnosis. Reserved for cases where noninvasive tests are inconclusive, as it is an invasive procedure with some risks.

Direct visualization of the digestive tract for early detection and treatment of complications such as varices, polyps, and cancers.

Advanced imaging for liver fibrosis assessment. Useful in patients where ultrasound-based methods are limited (e.g., obesity, ascites), and provides comprehensive liver assessment without radiation exposure.

Non-invasive assessment of liver stiffness. Ideal for routine monitoring of chronic liver diseases, helping guide treatment decisions and reducing the need for invasive procedure.